Menu

依普利酮国内怎么买?

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

A new generation of selective aldosterone antagonists has been approved as a new drug for the treatment of hypertension and other cardiovascular diseases. The combined use of eplerenone in the treatment of post-acute myocardial infarction heart failure and standard treatment drugs can reduce the total mortality rate in the treatment group by 15% (P=0.008); eplerenone and enalapril are equally effective in reversing left ventricular hypertrophy and hypertension, with fewer cough side effects, and the combined effect is more obvious; there are few adverse reactions, except for the adverse reactions of increased blood potassium, other adverse reactions are no different from the placebo group; there are almost no sex hormone-related side effects of spironolactone.

Precautions for eplerenone

1. Hyperkalemia: Hyperkalemia may occur; as hyperkalemia develops, dose reduction or treatment interruption may be required. If concomitant treatment with a moderate CYP3A4 inhibitor cannot be avoided, reduce the eplerenone dose. It is contraindicated in patients with potassium greater than 5.5 meq/L at the beginning of treatment.

2. Diabetes: Patients with diabetes and heart failure after myocardial infarction should use eplerenone with caution (especially those with proteinuria); it will increase the risk of hyperkalemia.

3. Liver damage: Patients with moderate to severe liver damage should use eplerenone with caution.

4. Kidney damage: As kidney function declines, the risk of hyperkalemia increases. Eplerenone should be used with caution in patients with mild renal impairment; eplerenone may be disabled depending on the indications and degree of impairment.

5. Drug-drug interactions: Eplerenone may have significant interactions with other drugs, requiring dose or frequency adjustment, additional monitoring, and/or the selection of alternative therapies.

6. Pregnancy: Untreated high blood pressure and heart failure are both associated with adverse pregnancy outcomes. The use of eplerenone is not recommended for the treatment of chronic isolated hypertension in pregnant women, and its use in women of reproductive potential should generally be avoided.

How to buy in China? Patients can seek consultation from overseas medical institutions (such as Medical Companion Travel) in China.

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。